| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $104.5M | +12.5% |
| Cost of Revenue | $13.1M | -2.6% |
| R&D Expense | $20.6M | +23.1% |
| SG&A Expense | $71.1M | -9.8% |
| Operating Income | -$63.9M | -37.4% |
| Pre-tax Income | -$70.3M | -50.5% |
| Income Tax | $108K | +63.6% |
| Net Income | -$70.4M | -50.5% |
| EPS (Basic) | -$4.51 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $194.5M | -28.5% |
| Accounts Receivable | $14.4M | +194.7% |
| Current Assets | $216.5M | -28.6% |
| Total Assets | $293.5M | -21.6% |
| Current Liabilities | $180.7M | +174.2% |
| Long-term Debt | $127.6M | +1.5% |
| Total Liabilities | $181.6M | -9.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$68.9M | -874.4% |
| Capital Expenditures | $1.4M | +110.0% |
| Investing Cash Flow | -$6.1M | -345.7% |
| Financing Cash Flow | -$11.0M | +49.3% |
| Free Cash Flow | -$70.3M | -808.4% |
| -72.1% |
| EPS (Diluted) | -$4.51 | -72.1% |
| Stockholders' Equity |
| $111.8M |
| -35.4% |